Anthony P. Conley

Oncology

210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions.

The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions.

Journal: Human vaccines & immunotherapeutics

Published: July 28, 2026

A pooled analysis of phase 2 clinical trials in advanced chordoma.

A pooled analysis of phase 2 clinical trials in advanced chordoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 07, 2026

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 18, 2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Journal: Cancer treatment reviews

Published: March 01, 2026

Drug Screening of Sarcoma Cells: Finding Shared Sensitivities.

Drug Screening of Sarcoma Cells: Finding Shared Sensitivities.

Journal: Cancer research communications

Published: February 16, 2026

Primary Synovial Sarcoma of the Abdomen and Pelvis.

Primary Synovial Sarcoma of the Abdomen and Pelvis.

Journal: American journal of clinical oncology

Published: December 04, 2025

Oncolytic adenoviral infection of chordoma achieves treatment efficacy associated with immunologic response and tumor microenvironmental alteration.

Oncolytic adenoviral infection of chordoma achieves treatment efficacy associated with immunologic response and tumor microenvironmental alteration.

Journal: Neuro-oncology

Published: October 23, 2025

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Journal: Frontiers in oncology

Published: June 12, 2025

TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.

TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.

Journal: Cancers

Published: March 07, 2025

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

Journal: ESMO open

Published: February 18, 2025

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience.

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience.

Journal: Frontiers in immunology

Published: January 28, 2025

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 23, 2024

Showing 1-12 of 105

Last Updated: 09/26/2026